Evidence map›Paper›PMID 34100135›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2021

Perceptions and acceptance of telemedicine among medical oncologists before and during the COVID-19 pandemic in Turkey.

Elif Sahin, Umut Kefeli, Devrim Cabuk, Ercan Ozden, Yagmur Cakmak, Muhammed Ali Kaypak, Mustafa Seyyar, Kazım Uygun

Open access · bronzeAbstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Elif SahinFaculty of Medicine, Department of Medical Oncology, Kocaeli University, Kocaeli, 41000, Turkey. dr_elifsahin48@hotmail.com.ORCID http://orcid.org/0000-0002-1976-3951
Umut KefeliFaculty of Medicine, Department of Medical Oncology, Kocaeli University, Kocaeli, 41000, Turkey.ORCID http://orcid.org/0000-0001-6126-5377
Devrim CabukFaculty of Medicine, Department of Medical Oncology, Kocaeli University, Kocaeli, 41000, Turkey.ORCID http://orcid.org/0000-0002-7871-6311
Ercan OzdenFaculty of Medicine, Department of Medical Oncology, Kocaeli University, Kocaeli, 41000, Turkey.ORCID http://orcid.org/0000-0002-1583-6068
Yagmur CakmakFaculty of Medicine, Department of Medical Oncology, Kocaeli University, Kocaeli, 41000, Turkey.ORCID http://orcid.org/0000-0001-5777-1066
Muhammed Ali KaypakFaculty of Medicine, Department of Medical Oncology, Kocaeli University, Kocaeli, 41000, Turkey.ORCID http://orcid.org/0000-0003-4503-0345
Mustafa SeyyarFaculty of Medicine, Department of Medical Oncology, Kocaeli University, Kocaeli, 41000, Turkey.ORCID http://orcid.org/0000-0002-4841-7994
Kazım UygunFaculty of Medicine, Department of Medical Oncology, Kocaeli University, Kocaeli, 41000, Turkey.ORCID http://orcid.org/0000-0002-4339-9918
Kocaeli Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAs a result of technological developments in healthcare services, telemedicine is becoming widespread. We aimed to determine the effect of COVID-19 on Turkish medical oncologists' opinions of telemedicine through a survey.

methodsThis study was conducted using an online questionnaire linked to an invitation e-mail sent to the members of the Turkish Medical Oncology Association mailing group between May and July 2020.

resultsOf the 110 (73 males and 37 females) medical oncologists who answered the questionnaire, the average age was 43.9 ± 7.29 (range: 31-64) years, and the majority of the respondents were academics. The most commonly used telemedicine method was store and forward (69.7%). Telemedicine use during clinical visits and multidisciplinary councils increased significantly during the COVID-19 pandemic (p < 0.001 in both cases).

conclusionThe use of telemedicine increased during the COVID-19 pandemic, and the pandemic has led oncologists to view telemedicine more positively.

Indexed as

COVID-19OncologistsTelemedicineAdultFemaleHumansMaleMiddle AgedPandemicsPerceptionSARS-CoV-2TurkeyCancerMedical oncologyTelehealthTelemedicineTeleoncology

Identifiers

PMID34100135
PMCPMC8183326
OpenAlexW3171394066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.